
| For Immediate Release |
Press
Release
|
|
Contact:
|
Raiford
Garrabrant
|
|
Cree,
Inc.
|
|
|
Director,
Investor Relations
|
|
|
Ph:
919-287-7895
|
|
|
Fax:
919-313-5615
|
|
|
Email:
raiford_garrabrant@cree.com
|
|
Ø
|
Acquired
LED Lighting Fixtures, which is recognized in the lighting industry as the
first company to develop a viable, energy-efficient, “no-compromise”
retrofit LED down light for general illumination. The
acquisition:
|
|
·
|
Expands
Cree’s market opportunity by providing direct access to the lighting
market
|
|
·
|
Enables
Cree to drive retrofit solutions to convert existing lighting
infrastructure to energy-efficient lighting and to accelerate the adoption
of LED lighting
|
|
·
|
Sets the stage for Cree to help obsolete the light bulb |
|
Ø
|
Announced
that Austin, TX, and the Tianjin Economic Development Area (TEDA) in
China, will join the growing LED City™
initiative. Austin plans to evaluate and deploy
state-of-the-art LED lighting technology across its municipal
infrastructure, and is offering rebates that cover approximately 30
percent of the upfront cost of LEDs to help businesses explore the
benefits of this new technology. The TEDA is the first city
area in China to join the program, and has partnered with Tianjin
Polytechnic University to develop the expertise necessary to accelerate
the adoption of LED lighting in
China.
|
| Ø |
Gross
margin was 35% of revenue.
|
| Ø |
Cash
flow from operations was $5.5
million.
|
| Ø |
Cash
and investments increased $36.4 million to $398.3 million from
Q2.
|
|
CREE, INC.
|
||||||||||||
|
CONSOLIDATED
STATEMENTS OF INCOME
|
||||||||||||
|
(in
thousands, except per share
data)
|
||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||
|
3/30/2008
|
3/25/2007
|
3/30/2008
|
3/25/2007
|
|||||||||
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||
|
Product
revenue
|
$ | 118,160 | $ | 82,318 | $ | 335,464 | $ | 261,258 | ||||
|
Contract
revenue
|
6,826 | 7,935 | 21,907 | 21,695 | ||||||||
|
Total
revenue
|
124,986 | 90,253 | 357,371 | 282,953 | ||||||||
|
Cost of product
revenue
|
75,935 | 55,279 | 219,766 | 163,778 | ||||||||
|
Cost of contract
revenue
|
5,502 | 6,002 | 17,520 | 16,934 | ||||||||
|
Total cost of
revenue
|
81,437 | 61,281 | 237,286 | 180,712 | ||||||||
|
Gross
margin
|
43,549 | 28,972 | 120,085 | 102,241 | ||||||||
|
Operating
expenses:
|
||||||||||||
|
Research and
development
|
15,405 | 15,619 | 43,083 | 44,272 | ||||||||
|
Sales, general and
administrative
|
21,076 | 13,115 | 57,449 | 37,636 | ||||||||
|
Amortization of acquisition
related intangibles
|
4,225 | 186 | 12,321 | 528 | ||||||||
|
(Gain) loss on disposal and
impairment of long-lived assets
|
(722 | ) | (154 | ) | 487 | 28 | ||||||
|
Total operating
expenses
|
39,984 | 28,766 | 113,340 | 82,464 | ||||||||
|
Operating
income
|
3,565 | 206 | 6,745 | 19,777 | ||||||||
|
Non-operating
income:
|
||||||||||||
|
Gain on sale of investments,
net
|
- | - | 14,117 | 11,411 | ||||||||
|
Interest and other non-operating
income, net
|
3,884 | 3,993 | 12,193 | 11,838 | ||||||||
|
Income from continuing operations
before income taxes
|
7,449 | 4,199 | 33,055 | 43,026 | ||||||||
|
Income tax expense
(benefit)
|
1,787 | (9,846 | ) | 7,885 | (649 | ) | ||||||
|
Net income from continuing
operations
|
5,662 | 14,045 | 25,170 | 43,675 | ||||||||
|
(Loss) income from
discontinued operations, net of related tax effect
|
(2 | ) | 7,085 | (176 | ) | 7,224 | ||||||
|
Net income
|
$ | 5,660 | $ | 21,130 | $ | 24,994 | $ | 50,899 | ||||
|
Diluted earnings per
share:
|
||||||||||||
|
Income from continuing
operations
|
$ | 0.06 | $ | 0.18 | $ | 0.29 | $ | 0.56 | ||||
|
(Loss) income from discontinued
operations
|
$ | (0.00 | ) | $ | 0.09 | $ | (0.00 |
)
|
$ | 0.09 | ||
|
Net income
|
$ | 0.06 | $ | 0.27 | $ | 0.29 | $ | 0.65 | ||||
|
Weighted average shares of
common
|
||||||||||||
|
stock
outstanding, basic
|
87,211 | 76,417 | 85,695 | 76,809 | ||||||||
|
Weighted average shares of
common
|
||||||||||||
|
stock
outstanding, diluted
|
88,905 | 77,134 | 87,506 | 77,729 | ||||||||
|
CREE,
INC.
|
||||||||||
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
||||||||||
|
(in
thousands)
|
||||||||||
|
3/30/2008
|
12/30/2007
|
|||||||||
|
(Unaudited)
|
(Unaudited)
|
6/24/2007
|
||||||||
|
Assets:
|
||||||||||
|
Current
assets:
|
||||||||||
|
Cash,
cash equivalents and short term investments
|
$ | 336,965 | $ | 295,121 | $ | 242,655 | ||||
|
Accounts
receivable, net
|
111,604 | 90,520 | 79,668 | |||||||
|
Inventory,
net
|
83,328 | 75,063 | 71,068 | |||||||
|
Income
taxes receivable and prepaid income taxes
|
2,000 | 3,246 | 7,947 | |||||||
|
Deferred
income taxes
|
20,886 | 19,939 | 23,573 | |||||||
|
Prepaid
expenses and other current assets
|
11,918 | 10,389 | 8,920 | |||||||
|
Assets
of discontinued operations
|
133 | 150 | 301 | |||||||
|
Total
current assets
|
566,834 | 494,428 | 434,132 | |||||||
|
Property
and equipment, net
|
351,222 | 354,252 | 372,345 | |||||||
|
Long-term
investments
|
61,369 | 66,828 | 68,363 | |||||||
|
Intangible
assets, net
|
129,643 | 89,573 | 96,138 | |||||||
|
Goodwill
|
187,874 | 144,334 | 141,777 | |||||||
|
Other
assets
|
9,349 | 3,526 | 3,475 | |||||||
|
Total
assets
|
$ | 1,306,291 | $ | 1,152,941 | $ | 1,116,230 | ||||
|
Liabilities
and Shareholders' Equity:
|
||||||||||
|
Current
liabilities:
|
||||||||||
|
Accounts
payable, trade
|
$ | 44,797 | $ | 36,612 | $ | 32,940 | ||||
|
Accrued
salaries and wages
|
14,337 | 10,197 | 10,241 | |||||||
|
Income
taxes payable
|
- | 6,856 | 4,504 | |||||||
|
Other
current liabilities
|
8,101 | 6,212 | 6,259 | |||||||
|
Liabilities
of discontinued operations
|
541 | 572 | 505 | |||||||
|
Total
current liabilities
|
67,776 | 60,449 | 54,449 | |||||||
|
Long-term
liabilities:
|
||||||||||
|
Deferred
income taxes
|
55,937 | 36,499 | 38,758 | |||||||
|
Contingent
tax reserves
|
4,852 | 5,792 | 5,792 | |||||||
|
Other
long-term liabilities
|
162 | 173 | 129 | |||||||
|
Long-term
liabilities of discontinued operations
|
835 | 924 | 1,103 | |||||||
|
Total
long-term liabilities
|
61,786 | 43,388 | 45,782 | |||||||
|
Shareholders'
Equity:
|
||||||||||
|
Common
stock
|
112 | 107 | 106 | |||||||
|
Additional
paid-in-capital
|
851,362 | 736,242 | 713,778 | |||||||
|
Accumulated
other comprehensive income
|
8,008 | 1,168 | 9,826 | |||||||
|
Retained
earnings
|
317,247 | 311,587 | 292,289 | |||||||
|
Total
shareholders' equity
|
1,176,729 | 1,049,104 | 1,015,999 | |||||||
|
Total
liabilities and shareholders' equity
|
$ | 1,306,291 | $ | 1,152,941 | $ | 1,116,230 | ||||
|
The
following is a reconciliation showing how Cree, Inc.'s third quarter
income statements for fiscal 2008
and 2007 would appear if they were adjusted for the items noted
below.
|
||||||||||||||||||||
|
CREE,
INC.
|
||||||||||||||||||||
|
Reconciling
Items to Q3 2008 & 2007 Financial Statements - GAAP to
Non-GAAP
|
||||||||||||||||||||
|
(in
thousands, except per share amounts)
|
||||||||||||||||||||
|
(Unaudited)
|
||||||||||||||||||||
|
Three
Months Ended
|
Three
Months Ended
|
|||||||||||||||||||
|
March
30, 2008
|
March
25, 2007
|
|||||||||||||||||||
|
GAAP
|
Adjustments
|
Non-GAAP
|
GAAP
|
Adjustments
|
Non-GAAP | |||||||||||||||
|
Product
revenue
|
$ | 118,160 | $ | - | $ | 118,160 | $ | 82,318 | $ | - | $ | 82,318 | ||||||||
|
Contract
revenue
|
6,826 | - | 6,826 | 7,935 | - | 7,935 | ||||||||||||||
|
Total
revenue
|
124,986 | - | 124,986 | 90,253 | - | 90,253 | ||||||||||||||
|
Cost
of product revenue
|
75,935 | (569 | ) |
(a)
|
75,366 | 55,279 | (580 | ) |
(a)
|
54,699 | ||||||||||
|
Cost
of contract revenue
|
5,502 | - | 5,502 | 6,002 | - | 6,002 | ||||||||||||||
|
Total
cost of sales
|
81,437 | (569 | ) | 80,868 | 61,281 | (580 | ) | 60,701 | ||||||||||||
|
Gross
margin
|
43,549 | 569 | 44,118 | 28,972 | 580 | 29,552 | ||||||||||||||
|
Gross
margin percentage
|
35 | % | 35 | % | 32 | % | 33 | % | ||||||||||||
|
Operating
expenses:
|
||||||||||||||||||||
|
Research
and development
|
15,405 | (1,095 | ) |
(a)
|
14,310 | 15,619 | (831 | ) |
(a)
|
14,788 | ||||||||||
|
Sales,
general and administrative
|
21,076 | (2,466 | ) |
(a)
|
18,610 | 13,115 | (1,331 | ) |
(a)
|
11,784 | ||||||||||
|
Amortization
of acquisition related intangibles
|
4,225 | (4,225 | ) |
(b)
|
- | 186 | (186 | ) |
(b)
|
- | ||||||||||
|
Gain
on disposal of assets
|
(722 | ) | - | (722 | ) | (154 | ) | - | (154 | ) | ||||||||||
|
Total
operating expenses
|
39,984 | (7,786 | ) | 32,198 | 28,766 | (2,348 | ) | 26,418 | ||||||||||||
|
Operating
income
|
3,565 | 8,355 | 11,920 | 206 | 2,928 | 3,134 | ||||||||||||||
|
Non-operating
income:
|
||||||||||||||||||||
|
Gain
(loss) on investments in securities
|
- | - | - | - | - | - | ||||||||||||||
|
Interest
and other non-operating income, net
|
3,884 | - | 3,884 | 3,993 | - | 3,993 | ||||||||||||||
|
Income
from continuing operations before income taxes
|
7,449 | 8,355 | 15,804 | 4,199 | 2,928 | 7,127 | ||||||||||||||
|
Income
tax expense (benefit)
|
1,787 | 2,005 |
(c)
|
3,792 | (9,846 | ) | 12,036 |
(d)
|
2,190 | |||||||||||
|
Net
income from continuing operations
|
5,662 | 6,350 | 12,012 | 14,045 | (9,108 | ) | 4,937 | |||||||||||||
|
(Loss)
gain from discontinued operations, net of related tax
|
(2 | ) | - | (2 | ) | 7,085 | (7,286 | ) |
(e)
|
(201 | ) | |||||||||
|
Net
income
|
$ | 5,660 | $ | 6,350 | $ | 12,010 | $ | 21,130 | $ | (16,394 | ) | $ | 4,736 | |||||||
|
Earnings
per diluted share:
|
||||||||||||||||||||
|
From
continuing operations
|
$ | 0.06 | $ | 0.07 | $ | 0.14 | $ | 0.18 | $ | (0.12 | ) | $ | 0.06 | |||||||
|
From
discontinued operations
|
$ | (0.00 | ) | $ | - | $ | (0.00 | ) | $ | 0.09 | $ | (0.09 | ) | $ | (0.00 | ) | ||||
|
From
net income
|
$ | 0.06 | $ | 0.07 | $ | 0.14 | $ | 0.27 | $ | (0.22 | ) | $ | 0.06 | |||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, basic
|
87,211 | - | 87,211 | 76,417 | - | 76,417 | ||||||||||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, diluted
|
88,905 | - | 88,905 | 77,134 | - | 77,134 | ||||||||||||||
|
(a)
Non-cash stock-based compensation expense of $569 in costs of product
revenue, $1,095 in research and development and $2,466 in sales, general
and administrative for the three months ended March 30, 2008 and $580 in
costs of product revenue, $831 in research and development and $1,331 in
sales, general and administrative for the three months ended March 25,
2007.
|
||||||||||||||||||||
|
(b)
Amortization expense of $4,225 for the three months ended March 30, 2008
and $186 for the three months ended March 25, 2007 recognized on
intangible assets resulting from acquisitions.
|
||||||||||||||||||||
|
(c)
Tax effects of non-cash stock-based compensation expense and amortization
related to acquisition related intangible assets.
|
||||||||||||||||||||
|
(d)
Tax effects for non-cash stock-based compensation, tax benefit related to
the change in estimate of contingent tax reserves associated with our
research and experimentation tax credit benefit related to the completion
of Internal Revenue Service audits of fiscal 2003, 2004 and 2005 Federal
tax returns, tax benefit related to the release of valuation allowances on
deferred tax assets related to Federal capital loss carry forwards and
income tax return to provision adjustments associated with the filing of
our fiscal 2006 federal tax returns.
|
||||||||||||||||||||
|
(e)
Tax benefit related to the the release of contingent tax reserves
associated with the completion of Internal Revenue Service audits of
fiscal 2003, 2004 and 2005 Federal tax returns.
|
||||||||||||||||||||
|
The
following is a reconciliation showing how Cree, Inc.'s
year to date income statements for fiscal 2008 and 2007 would
appear if they were adjusted for the items noted below.
|
||||||||||||||||||||
|
CREE,
INC.
|
||||||||||||||||||||
|
Reconciling
Items to Nine Months Financial Statements - GAAP to
Non-GAAP
|
||||||||||||||||||||
|
(in
thousands, except per share amounts)
|
||||||||||||||||||||
|
(Unaudited)
|
||||||||||||||||||||
|
Nine
Months Ended
|
Nine
Months Ended
|
|||||||||||||||||||
|
March
30, 2008
|
March
25, 2007
|
|||||||||||||||||||
|
GAAP
|
Adjustments
|
As
Adjusted
|
GAAP
|
Adjustments
|
As
Adjusted
|
|||||||||||||||
|
Product
revenue
|
$ | 335,464 | $ | - | $ | 335,464 | $ | 261,258 | $ | - | $ | 261,258 | ||||||||
|
Contract
revenue
|
21,907 | - | 21,907 | 21,695 | - | 21,695 | ||||||||||||||
|
Total
revenue
|
357,371 | - | 357,371 | 282,953 | - | 282,953 | ||||||||||||||
|
Cost
of product revenue
|
219,766 | (2,209 | ) |
(a)
|
217,557 | 163,778 | (2,787 | ) |
(a)
|
160,991 | ||||||||||
|
Cost
of contract revenue
|
17,520 | - | 17,520 | 16,934 | - | 16,934 | ||||||||||||||
|
Total
cost of sales
|
237,286 | (2,209 | ) | 235,077 | 180,712 | (2,787 | ) | 177,925 | ||||||||||||
|
Gross
margin
|
120,085 | 2,209 | 122,294 | 102,241 | 2,787 | 105,028 | ||||||||||||||
|
Gross
margin percentage
|
34 | % | 34 | % | 36 | % | 37 | % | ||||||||||||
|
Operating
expenses:
|
||||||||||||||||||||
|
Research
and development
|
43,083 | (3,031 | ) |
(a)
|
40,052 | 44,272 | (2,606 | ) |
(a)
|
41,666 | ||||||||||
|
Sales,
general and administrative
|
57,449 | (7,122 | ) |
(a)(b)
|
50,327 | 37,636 | (3,774 | ) |
(a)
|
33,862 | ||||||||||
|
Amortization
of acquisition related intangibles
|
12,321 | (12,321 | ) |
(c)
|
- | 528 | (528 | ) |
(c)
|
- | ||||||||||
|
Loss
on disposal and impairment of long-lived assets
|
487 | - | 487 | 28 | - | 28 | ||||||||||||||
|
Total
operating expenses
|
113,340 | (22,474 | ) | 90,866 | 82,464 | (6,908 | ) | 75,556 | ||||||||||||
|
Operating
income
|
6,745 | 24,683 | 31,428 | 19,777 | 9,695 | 29,472 | ||||||||||||||
|
Non-operating
income:
|
||||||||||||||||||||
|
Gain
(loss) on investments in securities
|
14,117 | (14,117 | ) |
(d)
|
- | 11,411 | (11,351 | ) |
(d)
|
60 | ||||||||||
|
Interest
and other non-operating income, net
|
12,193 | - | 12,193 | 11,838 | - | 11,838 | ||||||||||||||
|
Income
from continuing operations before income taxes
|
33,055 | 10,566 | 43,621 | 43,026 | (1,656 | ) | 41,370 | |||||||||||||
|
Income
tax expense
|
7,885 | 2,552 |
(e)
|
10,437 | (649 | ) | 13,706 |
(f)
|
13,057 | |||||||||||
|
Net
income from continuing operations
|
25,170 | 8,014 | 33,184 | 43,675 | (15,362 | ) | 28,313 | |||||||||||||
|
(Loss)
gain from discontinued operations, net of related tax
|
(176 | ) | - | (176 | ) | 7,224 | (7,566 | ) |
(g)
|
(342 | ) | |||||||||
|
Net
income
|
$ | 24,994 | $ | 8,014 | $ | 33,008 | $ | 50,899 | $ | (22,928 | ) | $ | 27,971 | |||||||
|
Earnings
per diluted share:
|
||||||||||||||||||||
|
From
continuing operations
|
$ | 0.29 | $ | 0.09 | $ | 0.38 | $ | 0.56 | $ | (0.20 | ) | $ | 0.36 | |||||||
|
From
discontinued operations
|
$ | (0.00 | ) | $ | - | $ | (0.00 | ) | $ | 0.09 | $ | (0.10 | ) | $ | (0.01 | ) | ||||
|
From
net income
|
$ | 0.29 | $ | 0.09 | $ | 0.38 | $ | 0.65 | $ | (0.29 | ) | $ | 0.36 | |||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, basic
|
85,695 | - | 85,695 | 76,809 | - | 76,809 | ||||||||||||||
|
Weighted
average shares of common
|
||||||||||||||||||||
|
stock
outstanding, diluted
|
87,506 | - | 87,506 | 77,729 | - | 77,729 | ||||||||||||||
|
(a)
Non-cash stock-based compensation expense of $2,209 in costs of product
revenue, $3,031 in research and development and $6,074 in sale, general
and administrative for the nine months ended March 30, 2008 and $2,787 in
costs of product revenue, $2,606 in research and development and $3,774 in
sale, general and administrative for the nine months ended March 25,
2007.
|
||||||||||||||||||||
|
(b)
Personal property assessment of $1,048 related to finalizing the audits of
our 2002 through 2007 property tax returns.
|
||||||||||||||||||||
|
(c) Amortization
expense of $12,321 for the nine months ended March 30, 2007 and $528 for
the nine months ended March 25, 2007 recognized on intangible assets
resulting from prior year acquisitions.
|
||||||||||||||||||||
|
(d)
Gain on the sale of 500,000 shares of Color Kinetics Incorporated common
stock during the nine months ended March 30, 2008 and on the sale of
931,000 shares of Color Kinetics Incorporated common stock during the nine
months ended March 25, 2007.
|
||||||||||||||||||||
|
(e)
Tax effects for non-cash stock-based compensation expense, personal
property tax assessment, the amortization of acquisition related
intangible assets and on the sale of Color Kinetics Incorporated common
stock.
|
||||||||||||||||||||
|
(f)
Tax effects for non-cash stock-based compensation, tax benefit related to
the change in estimate of contingent tax reserves associated with our
research and experimentation tax credit benefit related to the completion
of Internal Revenue Service audits of fiscal 2003, 2004 and 2005 Federal
tax returns, tax benefit of the release of valuation allowances on
deferred tax assets related to Federal capital loss carry forwards and
income tax return to provision adjustments associated with the filing of
our fiscal 2006 federal tax returns.
|
||||||||||||||||||||
|
(g)
Tax benefit related to the the release of contingent tax reserves
associated with the completion of Internal Revenue Service audits of
fiscal 2003, 2004 and 2005 Federal tax returns, and Gain realized as a
result of entering into a sublease agreement at Cree
Microwave.
|
||||||||||||||||||||